{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:53:22Z","timestamp":1789131202972,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["CA72851, CA181572, CA184792, CA202797, and CA227602"],"award-info":[{"award-number":["CA72851, CA181572, CA184792, CA202797, and CA227602"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2022,11,23]]},"DOI":"10.1038\/s41416-022-01974-5","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T05:03:38Z","timestamp":1662959018000},"page":"2016-2024","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A blood-based circulating microbial metagenomic panel for early diagnosis and prognosis of oesophageal adenocarcinoma"],"prefix":"10.1038","volume":"127","author":[{"given":"Ali H.","family":"Zaidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Yogi","family":"Pratama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashten N.","family":"Omstead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Gorbonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubab","family":"Mansoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Melton-Kreft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blair A.","family":"Jobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick L.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan J.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1396-6341","authenticated-orcid":false,"given":"Ajay","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,12]]},"reference":[{"key":"1974_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA: A Cancer J Clin"},{"key":"1974_CR2","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/ajg.2013.420","volume":"109","author":"S Kroep","year":"2014","unstructured":"Kroep S, Lansdorp-Vogelaar I, Rubenstein JH, Lemmens VEPP, van Heijningen EB, Aragon\u00e9s N, et al. Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, Spain, and The Netherlands. Am J Gastroenterol. 2014;109:336\u201344.","journal-title":"Am J Gastroenterol"},{"key":"1974_CR3","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1001\/jama.2013.226450","volume":"310","author":"SJ Spechler","year":"2013","unstructured":"Spechler SJ. Barrett esophagus and risk of esophageal cancer: a clinical review. J Am Med Assoc. 2013;310:627\u201336.","journal-title":"J Am Med Assoc"},{"key":"1974_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61874-7","volume":"10","author":"S Kambhampati","year":"2020","unstructured":"Kambhampati S, Tieu AH, Luber B, Wang H, Meltzer SJ. Risk factors for progression of Barrett\u2019s esophagus to high grade dysplasia and esophageal adenocarcinoma. Sci Rep. 2020;10:4899.","journal-title":"Sci Rep."},{"key":"1974_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.14740\/wjon1254","volume":"11","author":"EO Then","year":"2020","unstructured":"Then EO, Lopez M, Saleem S, Gayam V, Sunkara T, Culliford A, et al. Esophageal cancer: an updated surveillance epidemiology and end results database analysis. World J Oncol. 2020;11:55\u201364.","journal-title":"World J Oncol"},{"key":"1974_CR6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1080\/01635580701883011","volume":"60","author":"Y Fan","year":"2008","unstructured":"Fan Y, Yuan J-M, Wang R, Gao Y-T, Yu MC. Alcohol, tobacco and diet in relation to esophageal cancer: The Shanghai Cohort Study. Nutr Cancer. 2008;60:354\u201363.","journal-title":"Nutr Cancer"},{"key":"1974_CR7","doi-asserted-by":"publisher","first-page":"534","DOI":"10.4291\/wjgp.v5.i4.534","volume":"5","author":"L Alexandre","year":"2014","unstructured":"Alexandre L, Long E, Beales IL. Pathophysiological mechanisms linking obesity and esophageal adenocarcinoma. World J Gastrointest Pathophysiol. 2014;5:534\u201349.","journal-title":"World J Gastrointest Pathophysiol"},{"key":"1974_CR8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/alcalc\/agaa047","volume":"55","author":"X Yu","year":"2020","unstructured":"Yu X, Chen J, Jiang W, Zhang D. Alcohol, alcoholic beverages and risk of esophageal cancer by histological type: a dose-response meta-analysis of observational studies. Alcohol Alcohol. 2020;55:457\u201367.","journal-title":"Alcohol Alcohol"},{"key":"1974_CR9","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1001\/archinte.164.14.1482","volume":"164","author":"JT Chang","year":"2004","unstructured":"Chang JT, Katzka DA. Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma. Arch Intern Med. 2004;164:1482\u20138.","journal-title":"Arch Intern Med"},{"key":"1974_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0611-4","volume":"6","author":"NP Deshpande","year":"2018","unstructured":"Deshpande NP, Riordan SM, Casta\u00f1o-Rodr\u00edguez N, Wilkins MR, Kaakoush NO. Signatures within the esophageal microbiome are associated with host genetics, age, and disease. Microbiome. 2018;6:227.","journal-title":"Microbiome"},{"key":"1974_CR11","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/jnci\/djr203","volume":"103","author":"S Bhat","year":"2011","unstructured":"Bhat S, Coleman HG, Yousef F, Johnston BT, McManus DT, Gavin AT, et al. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. JNCI: J Natl Cancer Inst. 2011;103:1049\u201357.","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"1974_CR12","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/carcin\/22.8.1119","volume":"22","author":"X Chen","year":"2001","unstructured":"Chen X, Yang CS. Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis. 2001;22:1119\u201329.","journal-title":"Carcinogenesis"},{"key":"1974_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.gtc.2015.02.015","volume":"44","author":"AM Kaz","year":"2015","unstructured":"Kaz AM, Grady WM, Stachler MD, Bass AJ. Genetic and epigenetic alterations in Barrett\u2019s esophagus and esophageal adenocarcinoma. Gastroenterol Clin North Am. 2015;44:473\u201389.","journal-title":"Gastroenterol Clin North Am"},{"key":"1974_CR14","doi-asserted-by":"publisher","first-page":"e1007384","DOI":"10.1371\/journal.ppat.1007384","volume":"14","author":"TA Ajayi","year":"2018","unstructured":"Ajayi TA, Cantrell S, Spann A, Garman KS. Barrett\u2019s esophagus and esophageal cancer: links to microbes and the microbiome. PLoS Pathog. 2018;14:e1007384.","journal-title":"PLoS Pathog"},{"key":"1974_CR15","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.3748\/wjg.v25.i18.2149","volume":"25","author":"J Lv","year":"2019","unstructured":"Lv J, Guo L, Liu J-J, Zhao H-P, Zhang J, Wang J-H. Alteration of the esophageal microbiota in Barrett\u2019s esophagus and esophageal adenocarcinoma. World J Gastroenterol. 2019;25:2149\u201361.","journal-title":"World J Gastroenterol"},{"key":"1974_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/cancers10030083","volume":"10","author":"H Armstrong","year":"2018","unstructured":"Armstrong H, Bording-Jorgensen M, Dijk S, Wine E. The complex interplay between chronic inflammation, the microbiome, and cancer: understanding disease progression and what we can do to prevent it. Cancers. 2018;10:83.","journal-title":"Cancers"},{"key":"1974_CR17","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1053\/j.gastro.2017.09.046","volume":"154","author":"M Quante","year":"2018","unstructured":"Quante M, Graham TA, Jansen M. Insights into the pathophysiology of esophageal adenocarcinoma. Gastroenterology. 2018;154:406\u201320.","journal-title":"Gastroenterology"},{"key":"1974_CR18","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","volume":"30","author":"D Zheng","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020;30:492\u2013506.","journal-title":"Cell Res"},{"key":"1974_CR19","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.jcmgh.2021.08.013","volume":"13","author":"A Smet","year":"2022","unstructured":"Smet A, Kupcinskas J, Link A, Hold GL, Bornschein J. The role of microbiota in gastrointestinal cancer and cancer treatment: chance or curse? Cell Mol Gastroenterol Hepatol. 2022;13:857\u201374.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1974_CR20","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1158\/1055-9965.EPI-19-0008","volume":"28","author":"EJ Snider","year":"2019","unstructured":"Snider EJ, Compres G, Freedberg DE, Khiabanian H, Nobel YR, Stump S, et al. Alterations to the esophageal microbiome associated with progression from Barrett's esophagus to esophageal adenocarcinoma. Cancer Epidemiol, Biomark Prev. 2019;28:1687\u201393.","journal-title":"Cancer Epidemiol, Biomark Prev"},{"key":"1974_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S2468-1253(16)30086-3","volume":"2","author":"DRF Elliott","year":"2017","unstructured":"Elliott DRF, Walker AW, O\u2019Donovan M, Parkhill J, Fitzgerald RC. A non-endoscopic device to sample the oesophageal microbiota: a case-control study. lancet Gastroenterol Hepatol. 2017;2:32\u201342.","journal-title":"lancet Gastroenterol Hepatol"},{"key":"1974_CR22","doi-asserted-by":"publisher","first-page":"e0231789","DOI":"10.1371\/journal.pone.0231789","volume":"15","author":"LR Lopetuso","year":"2020","unstructured":"Lopetuso LR, Severgnini M, Pecere S, Ponziani FR, Boskoski I, Larghi A, et al. Esophageal microbiome signature in patients with Barrett\u2019s esophagus and esophageal adenocarcinoma. PLoS ONE. 2020;15:e0231789.","journal-title":"PLoS ONE"},{"key":"1974_CR23","doi-asserted-by":"publisher","first-page":"e00199","DOI":"10.14309\/ctg.0000000000000199","volume":"11","author":"S Peter","year":"2020","unstructured":"Peter S, Pendergraft A, VanDerPol W, Wilcox CM, Kyanam Kabir Baig KR, Morrow C, et al. Mucosa-associated microbiota in Barrett\u2019s esophagus, dysplasia, and esophageal adenocarcinoma differ similarly compared with healthy controls. Clin Transl Gastroenterol. 2020;11:e00199\u2013e00199.","journal-title":"Clin Transl Gastroenterol"},{"key":"1974_CR24","doi-asserted-by":"publisher","first-page":"e0129055","DOI":"10.1371\/journal.pone.0129055","volume":"10","author":"A Gall","year":"2015","unstructured":"Gall A, Fero J, McCoy C, Claywell BC, Sanchez CA, Blount PL, et al. Bacterial composition of the human upper gastrointestinal tract microbiome is dynamic and associated with genomic instability in a Barrett\u2019s esophagus cohort. PLoS ONE. 2015;10:e0129055.","journal-title":"PLoS ONE"},{"key":"1974_CR25","doi-asserted-by":"publisher","first-page":"6777","DOI":"10.1158\/0008-5472.CAN-17-1296","volume":"77","author":"BA Peters","year":"2017","unstructured":"Peters BA, Wu J, Pei Z, Yang L, Purdue MP, Freedman ND, et al. Oral microbiome composition reflects prospective risk for esophageal cancers. Cancer Res. 2017;77:6777\u201387.","journal-title":"Cancer Res"},{"key":"1974_CR26","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41586-020-2095-1","volume":"579","author":"GD Poore","year":"2020","unstructured":"Poore GD, Kopylova E, Zhu Q, Carpenter C, Fraraccio S, Wandro S, et al. Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature. 2020;579:567\u201374.","journal-title":"Nature"},{"key":"1974_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02401-3","volume":"22","author":"E Zozaya-Valdes","year":"2021","unstructured":"Zozaya-Valdes E, Wong SQ, Raleigh J, Hatzimihalis A, Ftouni S, Papenfuss AT, et al. Detection of cell-free microbial DNA using a contaminant-controlled analysis framework. Genome Biol. 2021;22:187.","journal-title":"Genome Biol"},{"key":"1974_CR28","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3389\/fonc.2019.00608","volume":"9","author":"Z Dong","year":"2019","unstructured":"Dong Z, Chen B, Pan H, Wang D, Liu M, Yang Y, et al. Detection of microbial 16S rRNA gene in the serum of patients with gastric cancer. Front Oncol. 2019;9:608.","journal-title":"Front Oncol"},{"key":"1974_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.canlet.2020.11.030","volume":"499","author":"Q Xiao","year":"2021","unstructured":"Xiao Q, Lu W, Kong X, Shao YW, Hu Y, Wang A, et al. Alterations of circulating bacterial DNA in colorectal cancer and adenoma: a proof-of-concept study. Cancer Lett. 2021;499:201\u20138.","journal-title":"Cancer Lett"},{"key":"1974_CR30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s40291-019-00390-5","volume":"23","author":"RI Chin","year":"2019","unstructured":"Chin RI, Chen K, Usmani A, Chua C, Harris PK, Binkley MS, et al. Detection of solid tumor molecular residual disease (MRD) using circulating tumor DNA (ctDNA). Mol diagnosis Ther. 2019;23:311\u201331.","journal-title":"Mol diagnosis Ther"},{"key":"1974_CR31","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s43018-020-0059-x","volume":"1","author":"L Adlung","year":"2020","unstructured":"Adlung L, Elinav E, Greten TF, Korangy F. Microbiome genomics for cancer prediction. Nat Cancer. 2020;1:379\u201381.","journal-title":"Nat Cancer"},{"key":"1974_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 2011;17:10\u201312.","journal-title":"EMBnet J"},{"key":"1974_CR33","doi-asserted-by":"crossref","unstructured":"Al-Ghalith GA, Hillmann B, Ang K, Shields-Cutler R, Knights D. SHI7 is a self-learning pipeline for multipurpose short-read DNA quality control. mSystems 2018;3: e00202-00217.","DOI":"10.1128\/mSystems.00202-17"},{"key":"1974_CR34","doi-asserted-by":"publisher","first-page":"D733","DOI":"10.1093\/nar\/gkv1189","volume":"44","author":"NA O\u2019Leary","year":"2016","unstructured":"O\u2019Leary NA, Wright MW, Brister JR, Ciufo S, Haddad D, McVeigh R, et al. Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res. 2016;44:D733\u2013745.","journal-title":"Nucleic Acids Res"},{"key":"1974_CR35","doi-asserted-by":"publisher","first-page":"e65088","DOI":"10.7554\/eLife.65088","volume":"10","author":"F Beghini","year":"2021","unstructured":"Beghini F, McIver LJ, Blanco-M\u00edguez A, Dubois L, Asnicar F, Maharjan S, et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. eLife. 2021;10:e65088.","journal-title":"eLife"},{"key":"1974_CR36","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114\u201320.","journal-title":"Bioinformatics"},{"key":"1974_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11938-018-0171-5","volume":"16","author":"M May","year":"2018","unstructured":"May M, Abrams JA. Emerging insights into the esophageal microbiome. Curr Treat Options Gastroenterol. 2018;16:72\u201385.","journal-title":"Curr Treat Options Gastroenterol"},{"key":"1974_CR38","doi-asserted-by":"publisher","first-page":"4960","DOI":"10.1038\/onc.2012.508","volume":"32","author":"HJ Choi","year":"2013","unstructured":"Choi HJ, Kim J, Do KH, Park S-H, Moon Y. Enteropathogenic Escherichia coli-induced macrophage inhibitory cytokine 1 mediates cancer cell survival: an in vitro implication of infection-linked tumor dissemination. Oncogene. 2013;32:4960\u20139.","journal-title":"Oncogene"},{"key":"1974_CR39","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1111\/1462-2920.12285","volume":"16","author":"I Amir","year":"2014","unstructured":"Amir I, Konikoff FM, Oppenheim M, Gophna U, Half EE. Gastric microbiota is altered in oesophagitis and Barrett\u2019s oesophagus and further modified by proton pump inhibitors. Environ Microbiol. 2014;16:2905\u201314.","journal-title":"Environ Microbiol"},{"key":"1974_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2093-8","volume":"16","author":"AH Zaidi","year":"2016","unstructured":"Zaidi AH, Kelly LA, Kreft RE, Barlek M, Omstead AN, Matsui D, et al. Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinoma. BMC Cancer. 2016;16:52.","journal-title":"BMC Cancer"},{"key":"1974_CR41","doi-asserted-by":"publisher","first-page":"9539","DOI":"10.2147\/CMAR.S261182","volume":"12","author":"R Zhang","year":"2020","unstructured":"Zhang R, Han D, Li L, Luo W, Liu J, Qian L. EphA5 silencing increases the radiosensitivity of ESCC cells through ATM-dependent pathway. Cancer Manag Res. 2020;12:9539\u201349.","journal-title":"Cancer Manag Res"},{"key":"1974_CR42","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3390\/biology10080697","volume":"10","author":"MR Gillespie","year":"2021","unstructured":"Gillespie MR, Rai V, Agrawal S, Nandipati KC. The role of microbiota in the pathogenesis of esophageal adenocarcinoma. Biology. 2021;10:697.","journal-title":"Biology"},{"key":"1974_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0658-1","volume":"7","author":"J Ouaknine Krief","year":"2019","unstructured":"Ouaknine Krief J, Helly de Tauriers P, Dumenil C, Neveux N, Dumoulin J, Giraud V, et al. Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab. J Immunother Cancer. 2019;7:176.","journal-title":"J Immunother Cancer"},{"key":"1974_CR44","doi-asserted-by":"crossref","unstructured":"Dong Z, Chen B, Pan H, Wang D, Liu M, Yang Y, et al. Detection of microbial 16S rRNA gene in the serum of patients with gastric cancer. Front Oncol. 2019;9:608.","DOI":"10.3389\/fonc.2019.00608"},{"key":"1974_CR45","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1007\/s10620-015-3662-4","volume":"60","author":"Y Kohata","year":"2015","unstructured":"Kohata Y, Nakahara K, Tanigawa T, Yamagami H, Shiba M, Watanabe T, et al. Rebamipide alters the esophageal microbiome and reduces the incidence of Barrett\u2019s esophagus in a rat model. Digestive Dis Sci. 2015;60:2654\u201361.","journal-title":"Digestive Dis Sci"},{"key":"1974_CR46","doi-asserted-by":"crossref","unstructured":"Kaakoush NO, Morris MJ. The oesophageal microbiome: an unexplored link in obesity-associated oesophageal adenocarcinoma. FEMS Microbiol Ecol. 2016;92.","DOI":"10.1093\/femsec\/fiw161"},{"key":"1974_CR47","doi-asserted-by":"publisher","first-page":"7878","DOI":"10.3748\/wjg.v20.i24.7878","volume":"20","author":"L Zhong","year":"2014","unstructured":"Zhong L, Zhang X, Covasa M. Emerging roles of lactic acid bacteria in protection against colorectal cancer. World J Gastroenterology: WJG. 2014;20:7878\u201386.","journal-title":"World J Gastroenterology: WJG"},{"key":"1974_CR48","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.ccell.2018.03.015","volume":"33","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Helmink BA, Spencer CN, Reuben A, Wargo JA. The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy. Cancer Cell. 2018;33:570\u201380.","journal-title":"Cancer Cell"},{"key":"1974_CR49","doi-asserted-by":"publisher","first-page":"110409","DOI":"10.1016\/j.biopha.2020.110409","volume":"129","author":"T Legesse Bedada","year":"2020","unstructured":"Legesse Bedada T, Feto TK, Awoke KS, Garedew AD, Yifat FT, Birri DJ. Probiotics for cancer alternative prevention and treatment. Biomedicine Pharmacother. 2020;129:110409.","journal-title":"Biomedicine Pharmacother"},{"key":"1974_CR50","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.sjbs.2019.09.004","volume":"27","author":"IA Rather","year":"2020","unstructured":"Rather IA, Bajpai VK, Ching LL, Majumder R, Nam G-J, Indugu N, et al. Effect of a bioactive product SEL001 from Lactobacillus sakei probio65 on gut microbiota and its anti-colitis effects in a TNBS-induced colitis mouse model. Saudi J Biol Sci. 2020;27:261\u201370.","journal-title":"Saudi J Biol Sci"},{"key":"1974_CR51","doi-asserted-by":"publisher","first-page":"E3573","DOI":"10.3390\/nu12113573","volume":"12","author":"S-Y Kim","year":"2020","unstructured":"Kim S-Y, Shin J-S, Chung K-S, Han H-S, Lee H-H, Lee J-H, et al. Immunostimulatory effects of live Lactobacillus sakei K040706 on the CYP-induced immunosuppression mouse model. Nutrients. 2020;12:E3573.","journal-title":"Nutrients"},{"key":"1974_CR52","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s10147-019-01521-y","volume":"25","author":"A Ota","year":"2020","unstructured":"Ota A, Morita S, Matsuoka A, Shimokata T, Maeda O, Mitsuma A, et al. Detection of bacteria in blood circulation in patients receiving cancer chemotherapy. Int J Clin Oncol. 2020;25:210\u20135.","journal-title":"Int J Clin Oncol"},{"key":"1974_CR53","doi-asserted-by":"publisher","first-page":"e56964","DOI":"10.1371\/journal.pone.0056964","volume":"8","author":"E Buc","year":"2013","unstructured":"Buc E, Dubois D, Sauvanet P, Raisch J, Delmas J, Darfeuille-Michaud A, et al. High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS ONE. 2013;8:e56964.","journal-title":"PLoS ONE"},{"key":"1974_CR54","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3390\/toxins5081462","volume":"5","author":"A Fabbri","year":"2013","unstructured":"Fabbri A, Travaglione S, Ballan G, Loizzo S, Fiorentini C. The cytotoxic necrotizing factor 1 from E. Coli: a Janus toxin playing with cancer regulators. Toxins. 2013;5:1462\u201374.","journal-title":"Toxins"},{"key":"1974_CR55","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41586-020-2080-8","volume":"580","author":"C Pleguezuelos-Manzano","year":"2020","unstructured":"Pleguezuelos-Manzano C, Puschhof J, Rosendahl Huber A, van Hoeck A, Wood HM, Nomburg J, et al. Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli. Nature. 2020;580:269\u201373.","journal-title":"Nature"},{"key":"1974_CR56","first-page":"651","volume":"12","author":"A Fabbri","year":"2022","unstructured":"Fabbri A, Bracci L. Immunomodulatory properties of CNF1 toxin from E. coli: implications for colorectal carcinogenesis. Am J Cancer Res. 2022;12:651\u201360.","journal-title":"Am J Cancer Res"},{"key":"1974_CR57","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.3390\/app9245491","volume":"9","author":"L Polimeno","year":"2019","unstructured":"Polimeno L, Barone M, Mosca A, Viggiani MT, Di Leo A, Debellis L, et al. Gut microbiota imbalance is related to sporadic colorectal neoplasms. A Pilot Study. Appl Sci. 2019;9:5491.","journal-title":"Appl Sci"},{"key":"1974_CR58","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fcimb.2019.00148","volume":"9","author":"DJ Castillo","year":"2019","unstructured":"Castillo DJ, Rifkin RF, Cowan DA, Potgieter M. The healthy human blood microbiome: fact or fiction? Front Cell Infect Microbiol. 2019;9:148.","journal-title":"Front Cell Infect Microbiol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01974-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01974-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01974-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:13:26Z","timestamp":1669162406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01974-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,12]]},"references-count":58,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,23]]}},"alternative-id":["1974"],"URL":"https:\/\/doi.org\/10.1038\/s41416-022-01974-5","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,12]]},"assertion":[{"value":"24 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all patients, and the study was approved by the institutional review boards of the participating institutions.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}